Valneva SE reported that 94% of participants maintained a strong immune response five years after a single dose of its chikungunya vaccine IXCHIQ®. The vaccine showed durable antibody persistence across all age groups, including those over 65, supporting its potential for long-term protection against chikungunya, a mosquito-borne disease with unpredictable outbreaks. Ongoing studies and real-world vaccination campaigns, such as the one in Brazil, aim to further validate the vaccine's effectiveness and safety. This long-lasting immunity is significant for both travelers and populations in endemic regions, especially in low- and middle-income countries with limited healthcare access.
Valneva's chikungunya vaccine IXCHIQ® is the story subject, providing context for health sector trends. For readers following health stocks, 122 of 150 US health-sector stocks rose while 25 fell as of Nov 10, 2026 12:51 WIB. Notable movers include FLNA at USD 0.50 with an 11.33% increase, TXG at USD 64.99 up 9.63%, and RLAY at USD 20.37 rising 9.52%.
Roche presented new data on its Alzheimer’s disease portfolio at the CTAD 2026 conference, highlighting advances in both pharmaceuticals and diagnostics. Key updates include Phase Ib/IIa data for trontinemab showing rapid amyloid clearance, the start...
Wix.com reported Q3 2026 revenue of $570 million, a 13% year-over-year increase, fueled by strong performance from its Base44 platform, which is nearing $250 million in annual recurring revenue. The company launched Studio Two, an advanced AI-powered...
U.S. spot Ethereum ETFs experienced net outflows totaling $184.51 million on November 9, marking the third consecutive day of withdrawals. The outflows were mainly driven by BlackRock's ETHA fund, which lost $119.28 million, surpassing inflows to the...
U.S. spot Bitcoin ETFs experienced net outflows for the third day in a row, with $201.08 million withdrawn on November 9, 2026. BlackRock’s IBIT fund led the outflows, losing $213.23 million, while Morgan Stanley’s MSBT was the only ETF to attract ne...
Autoliv, a global leader in automotive safety systems, has appointed Joachim Rosenberg as an independent director to its Board of Directors, increasing the board size from nine to ten members. Rosenberg brings extensive experience from his 20-year ca...
